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Background: Reference intervals (RIs) are ranges of upper and lower limits of a given analyte which are used for a
laboratory test to determine whether a disease is present or absent or to know if the patient is at risk for future
disease states. In Ethiopia, a country with highly diversified population groups and geographical sites, there are no
established RIs to metabolic analytes including the liver function test (LFT) analytes for the pediatric population
though it has been known that liver function assessment in this population is vital as a result of varied vulnerability
to both endogenous and xenobiotic substances.
Methods: A cross sectional study was conducted in Tikur Anbessa Specialized Hospital (TASH) and Teklehaymanot
Health Center (THC) from November 2010 to April 2011. 117 cord blood (from newborns) and venous blood
samples (from infants) were collected and analyzed using HumaStar 300. All pre-analytical, analytical and
post-analytical aspects were thoroughly controlled. A robust, CLSI/ IFCC recommended, method was used for the
determination of upper and lower end points covering 95% of the reference values of each analyte with respective
90% CIs using MedCalcW software.
Results: Combined RIs for newborns and infants were established for albumin, AST, ALP, direct bilirubin and total
bilirubin to be 3.88-5.82 g/dl, 16.1-55.4U/l, 130-831U/l, <0.41 mg/dl and <1.37 mg/dl respectively. But, separated RIs
were indicated for ALT and GGT as 1.2-23.1U/l and 6.94-24.8U/l ALT; and 30.6-160.7U/L and 10–28.2U/l GGT for
newborns and infants respectively. Some maternal and infantile factors were identified to affect the values of
analytes.
Conclusion: Almost all analytes were different from previously reported values for other target population of similar
age group, kit insert values and adult values. So, interpretation of values of these analytes in newborns and infants
of Ethiopian population sounds better to be performed by using such RIs taking the effect of some maternal and
infantile factors in to account.
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It is well known that reference intervals (RIs) depend on
many factors including the type of instrument and rea-
gents used, the principle or method for the test that is
being performed, the type of population being served and
the strength of quality assurance practiced at the labora-
tories [1]. Hence, establishing RIs continued to be a major
concern in many parts of the world since the RIs in-use* Correspondence: mulstud@gmail.com
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reproduction in any medium, provided the orwere established mainly for the Caucasian population, and
are often inappropriate for the diverse population that
many laboratories serve, and existing RIs need to be veri-
fied or validated as they were established decades ago with
methods and instrumentations that are now obsolete [2].
Moreover, establishment of RIs is becoming one agenda in
assurance of quality with in clinical laboratories [3,4].
In Ethiopia, a country with highly diversified population
groups and geographical sites, there are no established RIs
for metabolic analytes including the liver function test
(LFT) analytes for the pediatric population although some
efforts have been initiated for the adult population [5]. ItLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Summary of test methods applied for each
analyte
LFT analytes Analytical method
Aspartate aminotransferases (AST) IFCC Modified method, 37oC [7]
Alanine aminotransferases (ALT) IFCC Modified method, 37oC [8]
γ- glutamyltransferases (GGT) γ-glutamyl-p-nitroanilide substrate [9]
Alkaline Phosphatase (ALP) Optimized standard method [10]
Bilirubin (Direct + Total) Modified Jendrasic/Grof method [11]
Albumin BCG method [12]
LFT= Liver function tests, IFCC= International federation for Clinical Chemistry,
BCG=Bromocresol green.
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population is vital since there is varied vulnerability to
both endogenous and xenobiotic substances which is re-
sulted from developmental changes in the liver’s metabolic
activity. Prolonged action of drugs in newborns is attribu-
ted to the decreased capacity of the liver to metabolize,
detoxify and excrete xenobiotics. Neonatal jaundice is also
resulted because of decreased capacity of glucuronide
conjugation [6]. As a result, clinicians and researchers
have been adopting RIs from textbooks and package
inserts that were originally established based on Caucasian
population for the interpretation of pediatric laboratory
results though it is known that using non-Ethiopian RIs
may be misleading.
The purpose of this study is then to establish RIs for
the commonly requested LFT analytes in Ethiopian new-
borns and infants (≤ 1 year) and to determine the effect
of selected demographic variables on the values of these
analytes.
Method and materials
A cross sectional study was conducted in Tikur Anbessa
Specialized Hospital (TASH), department of Obstetrics and
Gynecology (OBGY) and Teklehaymanot Health Center
(THC) from November 2010 to April 2011. Newborns de-
livered in OBGY department of TASH with over 37 weeks
of gestation, ≥2500 g birth weight and no history of fetal
problems were enrolled in the study and their cord blood
was collected. Preterm newborns, newborns with <2500 g
birth weight, newborns requiring intensive resuscitation
and care, newborns from mothers with documented ante-
and/or intra-partum complications (gestational diabetes,
HIV, hepatitis B/C, eclampsia, etc.) were excluded. Simi-
larly, infants coming for immunization to THC without
any organic diseases or other diseases that can alter their
biochemical profile and those with weights > 2700 g were
included in the study and venous blood was collected.
Infants that have organic diseases and other diseases that
alter their biochemical profile were excluded from the
study. Infants who have taken medications that can affect
their biochemical profile were also excluded from the
study. Structured questionnaires were used in both cases
for the collection of selected demographic information.
The proposal of this study was reviewed by the De-
partment of Medical Laboratory Sciences research re-
view committee and by the Institutional Review Board
(IRB) of Addis Ababa University, Faculty of Medicine.
Informed (written) consent was obtained from mothers be-
fore specimen and data collection.
The pre-analytical, analytical and post-analytical phases
of the analyses were controlled throughout the study.
Moreover, a pilot study was conducted before the actual
data collection. HumaStar 300 analyzer (Human diagnos-
tics worldwide, Germany) was used for laboratory analysesand the methods applied for determination of analytes are
summarized in Table 1.
The data obtained from the analyzer and the question-
naires were entered in Microsoft excel sheet and ana-
lyzed by MedCalcW software Version 12.1.3. Tukey test
and D’Agostino-Pearson (DAP) test were used to detect
outlier values and to determine normality of distributions
of analyte values respectively. The effects of different vari-
ables on the values of the analytes were determined
through ANOVA and independent sample t-test. Then,
the upper and lower end points covering 95% of the refe-
rence value of the analytes were determined with their re-
spective 90% confidence intervals (CIs) by using the
robust method, according to the IFCC/CLSI recommen-
dation [13]. Haris and Boyd rule was applied to determine
whether partitioning of RIs should be done.
Result
Analytical performance of the methods
The maximum intra-assay coefficients of variations de-
tected (CVs) were 4.15% and 4.31% for normal and patho-
logical control sera respectively. Similarly, the maximum
inter-assay CVs were 3.31% and 4.95% for normal and
pathological control sera respectively (Table 2). Comme-
rcial quality control sera (HUMATROL N and P) were
included in every session of analyses. LJ charts were then
plotted and all the quality control results were in the ac-
ceptable limits.
Demographic data of study participants
A total of 117 study participants that fulfill the inclusion
criteria were included in this study among which 60
(51.3%) were newborns and 57 (48.7%) were infants. Over-
all, male study participants accounted for 53.8% where as
females accounted for 46.2%. Summary of the other selec-
ted demographic variables is presented in Tables 3 and 4.
RI calculations for the LFT analytes
According to Tukey test, no outlier values were detected
in all the studied analytes; and according to the DAP test,
Table 2 Intra- and inter assay CVs determined from duplicate analysis of quality control sera (HUMATROL N and P) for
LFT analytes
Analytes Intra assay CVs Inter assay CVs
Normal control Pathological control Normal control Pathological control
AST 2.42% 1.01% 3.31% 4.15%
ALT 0.63% 1.94% 3.11% 1.65%
GGT 1.50% 2.72% 2.86% 3.01%
ALP 1.83% 1.63% 1.58% 2.48%
Direct Bilirubin 2.00% 3.32% 2.93% 4.95%
Total Bilirubin 4.15% 4.31% 1.89% 3.64%
Albumin 0.89% 0.89% 3.07% 2.46%
CVs = Coefficient of variations, LFT = Liver function tests, N= normal, P = pathological, AST =Aspartate aminotransferases, ALT = Alanine aminotransferases,
GGT = γ- glutamyltransferases, ALP = Alkaline Phosphatase.
Table 3 summary of the distribution of selected demographic variables among newborns and infants
Demographic variables Newborns (n = 60) Infants (n = 57) p-value
Height x = 50.9 cm SD= 3.1 cm x = 60.5 cm SD= 8.5 cm
Weight x = 3120.0 g SD= 411.7 g x = 6956.1 g SD= 1996.2 g
Head circumference x = 35.3 cm SD= 3.1 cm x = 43.7 cm SD= 3.3 cm
Mode of deliveries
Normal vaginal delivery n = 43 (71.7%) NA NA
Cesarean section n= 17 (28.3%)
Sex
Male n = 32 (46.7%) n = 31 (54.4%) P = 0.9431}
Female n = 28 (53.3%) n = 26 (45.6%)
Maternal educational level
Unable to write and read n= 7 (11.7%) n = 7 (12.3%)
Below 8th grade n= 22 (36.7%) n = 34 (59.6%) P = 0.0380}
High school complete n = 16 (26.7%) n = 11 (19.3%)
Certificate and above n= 15 (25%) n = 5 (8.8%)
Maternal occupation
House wives n = 41(68.3%) n = 18 (31.6%)
Employed n= 10 (16.7%) n = 7 (12.3%) P < 0.0001}
Private business n = 7 (11.7%) n = 9 (15.8%)
Jobless n = 2 (3.3%) n = 23 (40.4%)
Maternal parity
Primiparous n = 39 (65%) n = 27 (47.4%) P = 0.0826}
Multiparous n = 21 (35%) n = 30 (52.6%)
Maternal alcohol consumption
Yes n = 11 (18.3%) n = 2 (4.3%) P = 0.0605}
No n= 49 (81.7%) n = 44 (95.7%)
Maternal chat chewing
Yes n = 0 (0%) n = 3 (6.5%) P = 0.1568}
No n= 60 (100%) n = 43 (93.5%)
Maternal cigarette smoking
Yes n = 0 (0%) n = 0 (0%) P = 0.2067}
No n= 60 (100%) n = 57 (100%)
} chi-square test, NA=not available, n=number, cm= centimeter, g=gram, x¯ = mean, SD= standard deviation.
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Table 4 Summary of feeding practice in infants of different age groups
Foods
Age groups Breast milk only Formula milk only Combination of breast
and formula milk
Additional foods Total
< 6 months 22 (78.6%) 2 (7.1%) 4 (14.3%) 0 (0.0%) 28 (49.1%)
> 6 months 7 (24.1%) 9 (31.0%) 7 (24.1%) 6 (20.7%) 29 (50.9%)
Total 29 (50.9%) 11 (19.3%) 11 (19.3%) 6 (10.5%) 57 (100%)
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normally distributed after logarithmic transformation.
All of the LFT analytes were different in newborns and
infants though only ALT and GGT required separated
RIs (Figure 1). The combined RIs (for newborns and
infants) of AST, ALP, direct bilirubin, total bilirubin
and albumin were 16.1-55.4 U/L, 130–831 U/L, below
0.41 mg/dl, below 1.37 mg/dl and 3.88-5.82 g/dl respec-
tively. The separated RIs of ALT were calculated to be
1.2-23.1 U/L and 6.94-24.8 U/L for newborns and infants
respectively; while the separated RIs of GGT were deter-
mined to be 30.6-160.7 U/L and 10–28.2 U/L respectively.
Maternal alcohol consumption during the periods of
gestation was the only factor that affected the values of
some LFT analytes (AST and ALP) in newborns (Table 5).
But in infants, age group, gender and feeding practice
influenced the values of some of LFT analytes (Table 6).
Some of the effects were even strong enough to statisti-
cally dictate separated RIs.
Up on comparison of the RIs obtained from this study
(Table 7) with previously reported values of similar age
group, visually significant differences were seen. The va-
lues were also different from respective adult values de-
termined for adult Ethiopian population (Table 8).
Discussion
This study showed that the activity of AST in newborns
was higher than in infants (p = 0.026, Figure 1a) even
though separated RI was not justifiable according to
Harris and Boyd rule. The increment could be due to
the release of placental AST in to fetal circulation [17].
Both the upper and lower limits of this RI were similar
to the previously reported values of the same age group
population and to adult values. But, both upper and lower
limits were higher than those provided in manufacturer
kit inserts. Though the RI given on manufacture kit inserts
lack traceability, it is clearly seen that the values are lower
even than values given for adult let alone the pediatric
population (Table 8).
According to Elinav et al., there is a significant asso-
ciation between age and serum ALT activity in which a
characteristic inverted ‘U’ curve pattern is attained by ALT
with age i.e. it increases up to 40–55 years and then
decreases [24]. Accordingly, slightly lowered activity of
ALT was found in newborns (Figure 1b) that necessitatedseparated RIs. This can be explained in the view that the
fetus in normal physiological circumstances is dependent
on the mother for frequent supply of glucose without a
significant need of glucose production by gluconeogenesis
[25]. But during infancy, there is increased gluconeoge-
nesis and as a result the key enzyme in this process which
converts alanine in to alpha ketoglutarate at the initial
step, ALT, is increased [26]. The RIs determined for ALT
were generally lower than values provided for children up
to 3 years of age and adults (Table 8) which could be due
to age difference, while they were comparable with cord
blood values given in literature.
It has been documented that serum ALP activity can
increase up to six times the upper reference limit of
adult values during infancy and childhood, which then
decreases to attain adult values by the age of 16–20 years
the predominating isoenzyme being of bone origin [27].
Significant increment of ALP activity is detected in infants
over newborns (p= 0.0001, Figure 1d) without a need for
separated RIs. This RI was different from published values
for similar age group population and adult population;
particularly, the upper limit of the RI was higher (Table 8).
As explained by Lucas et al., increased ALP activity might
be related to slower growth rate [28].
Despite the fact that the increased activity is neither
having any known clinical significance nor resulted from
any fetal forms of the enzyme besides indicating imma-
turity [29], the activity of GGT was higher in newborns
(p< 0.0001, Figure 1c) than in infants. In newborns, GGT
activity may reach up to 5–7 times the upper limit of nor-
mal for adults [30]. The difference also required separated
RIs. The RI of newborns was narrower than the value pro-
vided by Perkins et al. [18] in which the upper limit was
almost a double of the current study while the lower limit
was nearly equivalent. But, RI for infantile GGT activity
was higher than the value given for children up to 3 years
of age (Table 8) while the RI, more specifically, the upper
limit was significantly lower than adult values as adults
are known to have raised serum GGT activity induced
from many factors including alcohol consumption [31].
As shown in Figure 1e and 1f, both direct and total bili-
rubin values were higher in cord blood than in infants
(p= 0.0067 and p< 0.0001 respectively) although the dif-
ferences failed to illustrate separated RIs. The increment
in cord blood bilirubin could be resulted since only infants
Figure 1 Box and Whisker plots indicating the difference among newborns and infants in values of AST (a), ALT (b), GGT (c) ALP (d),
direct bilirubin (e), total bilirubin (f) and albumin (g).
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Moreover, red cell degradation may be initiated in the
fetus before delivery. The abrupt interruption in the net
influx of bilirubin across the placenta from the fetus
to the mother may also lead to further increase in the cord
bilirubin [32]. The direct bilirubin RI was higher than
values given in literature and manufacturer kit inserts
(Table 8) but lower than values indicated for adultpopulation. Similarly, the RI of total bilirubin was higher
than values given for children and adults. But, it was sig-
nificantly lower than values provided by manufacture kit
inserts for newborns.
In this study, statistically significant variations were de-
tected regarding albumin (p= 0.0002) values among new-
borns and infants (Figure 1g) even though the Harris
and Boyd test failed to denote separated RIs. The slightly
Table 5 Results of independent sample t-tests(p-values) which were performed to see effect of maternal and neonatal
factors on the values of LFT analytes in newborns
Analyte Variables
Sex Maternal parity Mode of delivery Maternal alcohol
consumption
Harris and Boyd
AST 0.181 0.133 0.080 0.003 Separate RI
ALT 0.448 0.359 0.186 0.184 No separate RI
ALP 0.352 0.510 0.189 0.011 Separate RI
GGT 0.642 0.572 0.602 0.970 No separate RI
Direct bilirubin 0.846 0.933 0.452 0.455 No separate RI
Total bilirubin 0.935 0.745 0.561 0.180 No separate RI
Albumin 0.053 0.155 0.158 0.256 No separate RI
LFT= Liver function tests, RI=Reference interval, AST=Aspartate aminotransferases, ALT=Alanine aminotransferases, GGT= γ- glutamyltransferases, ALP=Alkaline
Phosphatase.
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fully be explained by decreased synthesis as a result of
liver immaturity since they are capable of endogenous al-
bumin production even from early pregnancy on [33,34].
As a result, it could also be originated from other factors
that govern albumin level like increased degradation, in-
travascular space and transcapillary escape [35,36]. The
lower limit of albumin in newborns and infants was higher
than that given in literature (Table 8) for these popula-
tions, but it was comparable to the adult values and kit
inserts values except that it was lower than the values
given for adult Ethiopian population. In contrast, the
upper limit was higher than all the comparators used
apart from the fact that it was lower than adult values
determined in Ethiopia.
It has been indicated that a cord blood albumin value
of >3.3 g/dl [37] and bilirubin value of <1.75 mg/dl [38]
are presumed as safe levels in which there is minimal
chance of neonatal jaundice. But, in this study, even the
minimum value of albumin was higher than the aforemen-
tioned one. However, it needs further study to ascertainTable 6 Results of independent sample t-tests* and ANOVA†








AST 0.514* 0.304* 0.397† 0.488*
ALT 0.080* 0.030* 0.354† 0.764*
ALP 0.002* 0.160* 0.007† 0.050*
GGT 0.000* 0.672* 0.928† 0.476*
Direct
bilirubin
0.090* 0.572* 0.458† 0.673*
Total bilirubin 0.765* 0.585* 0.835† 0.143*
Albumin 0.001* 0.860* 0.168† 0.349*
ANOVA = analysis of variance, LFT = Liver function tests, RI= Reference interval, A
glutamyltransferases, ALP =Alkaline Phosphatase.whether our newborns are really safe from subsequent oc-
currence of neonatal jaundice at the provided albumin
level.
Maternal alcohol consumption during the periods of
gestation was found to affect the values of AST (p= 0.003)
and ALP (p= 0.011). The AST values were higher while
ALP values were lower in newborns from mothers con-
suming alcohol during the period of gestation with sepa-
rated RIs indicated for both variations (Table 7). These
results need further investigation using increased sample
sizes since the actual number of mothers consuming al-
cohol during the periods of gestation was actually 11 in
this study.
In the infantile population, age dependent variation of
ALP (p= 0.002) and GGT (p= 0.000) activity was detected
in which the activities of both enzymes were higher in
infants of age below 6 months though only the variation
in GGT needed separated RI. The activity of GGT has
been reported to decline in the postnatal periods reaching
adult values by the age of 5–7 months [30]. Since majority









0.241* 0.090* No separate RI
0.522* 0.369* Separate RI
0.678* 0.153* No separate RI
0.810* 0.928* Separate RI
0.210* 0.622* No separate RI
0.661* 0.714* No separate RI
0.111* 0.759* Separate RI
ST = Aspartate aminotransferases, ALT = Alanine aminotransferases, GGT = γ-
Table 7 Summary of the RIs LFT analytes in cord and infant blood samples
Analyte n Min. value Max. value DAP test Mean (95% CI) Lower limit (90% CI) Upper limit (90%CI) RI




































































ALP (U/l) Combined 117 163 954 P = 0.141 488 (456–520) 130 (112–155) 831 (781–848) 130-831
Newborns
Alcohol Yes 11 163 418 P = 0.89 291 (241–341) 112 (78–133) 463 (435–513) 112-463
Alcohol No 49 176 954 P = 0.82 385 (346–428) 180 (169–206) 808 (773–874) 180-808
GG (U/l) Newborns 60 45 155 P = 0.320 96 (87.6-104) 30.6 (27.8-37.3) 160.7 (150–171) 30.6-160.7
Infants 57 11 26 P = 0.272 19 (17.9-20.2) 10 (9.2-12.4) 28.2 (26.8-29.4) 10-28.2
< 6 months 28 14 26 P = 0.673 21.2 (20–22.4) 14.8 (13.5-15.9) 27.9 (26.6-29.6) 14.8-27.9
> 6 months 29 11 26 P = 0.233 17 (15.2-18.7) 6.9 (1.9-8.0) 26.1 (23.5-28.2) 6.9-26.1
Direct bilirubin
(mg/dl)
Combined 117 0.01 0.46 P = 0.075 0.18 (0.16-0.20) −0.06 [−0.07]-[−0.04] 0.41 (0.39-0.43) Below 0.41
Total bilirubin
(mg/dl)
Combined 117 0.04 1.37 P = 0.130 0.69 (0.62-0.75) −0.01 [−0.01]-[0.02] 1.37 (1.31-1.40) Below 1.37
LFT= Liver function tests, RI=Reference interval, AST=Aspartate aminotransferases, ALT=Alanine aminotransferases, GGT= γ- glutamyltransferases, ALP =Alkaline Phosphatase, n=number, min=minimum,




















Table 8 Comparing the RIs of LFTs in newborns and infants with values for the same age group and for adults in previous studies and kit inserts





Current study 16.1-55.4 Newborns = 1.2-23.1 130-831 Newborns = 30.6-160.7 Below 0.41 Below 1.37 3.88-5.82
Infants = 6.94-24.8 Infants = 10–28.2
Perkins et al. [18]
(cord blood)
17-59 4-27 87-303 27-339 3.0-4.1
Lockitch et al. [19]
(Up to 3 years)
20-60 5-45 145-320 6-19 Below 0.12 0.18-0.99 3.4-4.2
Kit inserts Men≤ 37 [20] Men≤ 42 [21] Children≤ 15 years
≤ 644 [22]
Men= 11-61 [23] ≤ 0.25 [14] At birth≤ 5 [14] 3.8-5.1 [15]
Women≤ 31 [20] Women≤ 32 [21] Men= 80–306 [22] Women= 9–39 [23] 5 days≤ 12 [14]
Women= 64–306 [22] 1 month≤ 1.5 [14]
Adults≤ 1.1 [14]
Adult values 14-60 [16] 8-61 [16] 0.02-0.52 [16] 0.17-2.16 [16] 5.8-8.8 [16]
Men= 10-58 [5] Men= 6–42 [5] Men= 109–353 [5] Men= 8.5-63 [5] Men= 0.2-1.47 [5] Men= 0.6-2.3 [5]
Women= 6-45 [5] Women= 4-27.4 [5] Women= 97–294 [5] Women= 6–59 [5] Women= 0.2-1.45 [5] Women= 0.5-1.72 [5]
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explained by absorption of maternal GGT mixed with
breast milk [39].
Sex dependent variation of ALT was also revealed in
which the activity of this enzyme is slightly higher in
females with separated RIs indicated. Though separated
RI is not indicated, ALP activity tended to be lower in
infants on additional food to breast feeding. Albumin also
showed age dependent variation in infants with separated
RIs (Table 7). Infants of age group above 6 months were
having higher values of albumin (p= 0.001) as a result of
gradual increment through age [19].
Conclusion
Even though all LFT analytes showed difference in new-
borns and infants, ALT and GGT activities only necessi-
tated separated RIs. Some infantile and maternal factors
like age, sex, feeding practice and maternal alcohol con-
sumption during gestational periods were important factors
that affected the values of analytes in serum of newborns
and infants.
Almost all LFT analytes were different from previously
reported values for other target population of similar age
group, kit insert values and RIs given for adult popula-
tions. Hence, interpretation of LFT analytes in Ethiopian
pediatric population sounds better to be performed by
using such RIs taking the effect of infantile and maternal
factors in to account.
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